Taipei, Friday, November 24, 2017 17:29 (GMT+8)
cloudy
Taipei
19°C
PCB maker Apex to see capacity utilization rate drop to 80% in 4Q12 - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Thursday 11 October 2012]
  • APEX Medical
  • Performance
    The company's stock price closed at NT$30 on the TSE on Thursday, November 23, 2017.
    The company has reported consolidated revenues of NT$155 million for October 2017, representing a 7.4% drop on month and 0.7% drop on year.
    For the third quarter of 2017, the company totaled NT$566 million in consolidated revenues, up 4.5% sequentially and up 31.8% on year.
    Brief

    Full name: APEX Medical

    Chinese name: 雃博股份有限公司

    Short name: Apex

    Stock code: 4106

    Tax ID: 23632773

    Market: TSE

    Established: 17 Mar 1990

    Paid in capital: NT$833.86 million

    Listed on TSE: 8 Nov 2004

    Listed on OTC: 22 Jan 2002

    Listed on ESB: 2 Jan 2002

    Public since: 19 Jul 1999

    Website: cht.apexmedical.com.tw

  • Latest stock
    Apex [4106] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    24-Nov 91 57 2,732,350 30.00 30.15 30.00 30.05+0.05+0.17% 30.00 30.05
    23-Nov 72 49 2,156,000 29.85 30.05 29.85 30.00+0.00+0.00% 30.00 30.05
    22-Nov 138 83 4,148,800 30.20 30.20 29.90 30.00+0.00+0.00% 29.95 30.00
    21-Nov 152 99 4,555,150 30.00 30.20 29.80 30.00+0.15+0.50% 29.95 30.00
    20-Nov 267 140 7,975,950 29.80 30.20 29.65 29.85+0.15+0.51% 29.85 29.90
    17-Nov 155 92 4,610,150 29.80 30.30 29.65 29.70-0.05-0.17% 29.70 29.75
    16-Nov 61 44 1,816,100 29.85 29.85 29.70 29.75-0.10-0.34% 29.75 29.80
    15-Nov 67 59 1,993,900 29.60 29.90 29.60 29.85+0.15+0.51% 29.80 29.90
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Oct 2016 - Oct 2017 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Oct-17

    155

    (7.4%)

    (0.7%)

    1,732

    6.9%

    Sep-17

    167

    (20.6%)

    22.2%

    1,577

    7.7%

    Aug-17

    211

    12.2%

    38%

    1,410

    6.2%

    Jul-17

    188

    6.4%

    34.3%

    1,199

    2.1%

    Jun-17

    176

    (11.9%)

    1%

    1,011

    (2.3%)

    May-17

    200

    20.9%

    16.4%

    835

    (2.9%)

    Apr-17

    166

    (17.5%)

    (7.7%)

    635

    (7.8%)

    Mar-17

    201

    46.7%

    13.5%

    469

    (7.8%)

    Feb-17

    137

    4.2%

    1.5%

    268

    (19.1%)

    Jan-17

    131

    (35%)

    (33.2%)

    131

    (33.2%)

    Dec-16

    202

    21.6%

    2.1%

    1,989

    (1.4%)

    Nov-16

    166

    6.6%

    2.8%

    1,787

    (1.8%)

    Oct-16

    156

    13.8%

    (8.4%)

    1,621

    (2.3%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, November 2017

    Apex: Consolidated revenues, 3Q16 - 3Q17 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    3Q-17

    566

    4.5%

    31.8%

    1,577

    7.7%

    2Q-17

    542

    15.6%

    3%

    1,011

    (2.3%)

    1Q-17

    469

    (10.8%)

    (7.8%)

    469

    (7.8%)

    4Q-16

    526

    22.4%

    (0.8%)

    1,990

    (1.3%)

    3Q-16

    430

    (18.4%)

    2.8%

    1,465

    (1.5%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, November 2017

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 3Q16 - 3Q17 (NT$k)

    Item

    3Q-2017

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    Current assets

    1,308,761

    1,338,039

    1,233,710

    1,268,131

    1,108,550

    Intangible assets

    446,802

    420,386

    415,497

    432,513

    445,656

    Non-current assets

    1,304,102

    1,317,025

    1,273,566

    1,322,918

    1,318,301

    Assets

    2,612,863

    2,655,064

    2,507,276

    2,591,049

    2,426,851

    Current liabilities

    718,649

    804,349

    678,421

    738,224

    869,126

    Non-current liabilities

    297,752

    296,389

    295,241

    294,782

    5,427

    Liabilities

    1,016,401

    1,100,738

    973,662

    1,033,006

    874,553

    Stockholders' equity

    1,596,462

    1,554,326

    1,533,614

    1,558,043

    1,552,298

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, November 2017

    Apex: Consolidated income statement, 3Q16 - 3Q17 (NT$k)

    Item

    3Q-2017

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

     

     

     

     

    469,035

     

    0

     

     

     

    Operating revenue

    566,344

    120.7%

    542,086

    115.6%

    469,035

    100%

    525,757

     

    429,703

    75.9%

    Gross profit (loss) from operations

    235,788

    50.3%

    246,958

    52.7%

    211,420

    45.1%

    217,533

    41.4%

    192,185

    33.9%

    Operating expenses

    196,531

    41.9%

    182,293

    38.9%

    170,935

    36.4%

    188,896

    35.9%

    167,287

    29.5%

    Operating income (loss)

    39,257

    8.4%

    64,665

    13.8%

    40,485

    8.6%

    28,637

    5.4%

    24,898

    4.4%

    Non-operating expenses and losses

    1,814

    0.4%

    -3,328

    -0.7%

    -3,882

    -0.8%

    -8,381

    -1.6%

    3,988

    0.7%

    Income from continuing operations before income tax

    41,071

    8.8%

    61,337

    13.1%

    36,603

    7.8%

    20,256

    3.9%

    28,886

    5.1%

    Net income (loss)

    22,938

    4.9%

    48,498

    10.3%

    26,213

    5.6%

    15,624

    3%

    26,264

    4.6%

    Diluted earnings per share (NT$)

    0.3

     

    0.5

     

    0.3

     

    0.2

     

    0.3

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, November 2017

  • APEX Medical full profile

24-Nov-2017 markets closed

 LastChange

TAIEX (TSE)10854.09-0.48-0% 

TSE electronic467.56+1.55+0.33% 

GTSM (OTC)150.19-0.01-0.01% 

OTC electronic229.62+0.24+0.1% 

Global notebook shipment forecast, 2017 and beyond
Global AP demand forecast, 2017-2020
Global notebook shipment forecast, 2017 and beyond
  • The 10nm competition

    TSMC and Samsung have been competing for clients for the 10nm node.

  • Qualcomm royalty row

    Qualcomm faces pressure to renegotiate royalty terms with clients as more phone vendors reportedly mull following Apple's lead in suspending payments...

  • TSMC 3nm fab

    TSMC will build its 3nm fab in southern Taiwan.

  • SEMICON Taiwan 2017

    Semiconductor equipment and material suppliers are showcasing their latest products and technologies at SEMICON Taiwan 2017 in Taipei September 13-15.

  • China AMOLED panel capacity expansion forecast, 2016-2020

    This Digitimes Research Special Report examines the China AMOLED industry, focusing on the expansion capacity of the makers, the current implementation plans of major smartphone vendors in the market and the technological hurdles faced by the China makers.

  • Global AP demand forecast, 2017-2020

    Digitimes Research expects global AP shipments to surpass the 1.9 billion mark in 2017, with smartphones remaining the main application. Qualcomm will be leading the market in 2017, as other players continue playing catch up and scramble for funds to invest in more diverse applications.

  • Global notebook shipment forecast, 2017 and beyond

    This Digitimes Special Report examines key factors in the notebook industry, including products, vendors and ODMs, that will affect total shipments in 2017 and through 2021.